With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed drugs to the market.
Source link
Subscribe
Join our community for exclusive content, expert insights, and tips for a healthier, happier you. Subscribe now for weekly updates delivered straight to your inbox!